CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $521,860
- in 2 filings
Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-03 | Patel Sushil Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2021-04-15 | Love Colin Chief Operating Officer | Sale | −27,300 | $30.69 | $838K | 898,509 |
| 2021-04-15 | Love Colin Chief Operating Officer | Sale | −2,700 | $29.98 | $81K | 895,809 |
| 2021-04-01 | Esposito Pamela Chief Business Officer | Grant or award | +34,165 | 210,159 | ||
| 2021-04-01 | Esposito Pamela Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +51,250 | 51,250 | ||
| 2021-04-01 | Pirzkall Andrea Chief Medical Officer | Grant or award | +20,500 | 21,500 | ||
| 2021-04-01 | Pirzkall Andrea Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +30,750 | 30,750 | ||
| 2021-04-01 | Franchi Jean M. Chief Financial Officer | Grant or award | +46,035 | 46,035 | ||
| 2021-04-01 | Franchi Jean M. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +69,050 | 69,050 | ||
| 2021-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award | +76,865 | 1,820,983 | ||
| 2021-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award · Employee Stock Option (right to buy) | +115,300 | 115,300 | ||
| 2021-04-01 | Astley-Sparke Philip Chief Executive Officer | Grant or award | +85,415 | 1,340,712 | ||
| 2021-04-01 | Astley-Sparke Philip Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +128,125 | 128,125 | ||
| 2021-04-01 | Love Colin Chief Operating Officer | Grant or award | +39,285 | 925,809 | ||
| 2021-04-01 | Love Colin Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +58,925 | 58,925 | ||
| 2021-04-01 | Rhodes Jason P Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2021-04-01 | Levitsky Hyam Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2021-04-01 | Lewis Tanya Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2021-04-01 | Pucci Paolo Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2021-04-01 | Weinand Dieter Director | Grant or award · Stock Option (right to buy) | +24,750 | 24,750 |
Page 14 of 19 · 365 trades